There are 2949 resources available
IO combinations in first-line advanced HCC: Current evidence and ongoing trials
Presenter: Peter Galle
Session: AstraZeneca - Current status and future directions for immunotherapy in hepatocellular carcinoma
Resources:
Webcast
IO combinations early or intermediate-stage HCC: Current evidence and ongoing trials
Presenter: Ghassan Abou-Alfa
Session: AstraZeneca - Current status and future directions for immunotherapy in hepatocellular carcinoma
Resources:
Webcast
Putting it all together: Case discussions
Presenter: Bruno Sangro
Session: AstraZeneca - Current status and future directions for immunotherapy in hepatocellular carcinoma
Resources:
Webcast
ALK+ and ROS1+ NSCLC: Optimising patient outcomes
Presenter: Todd Bauer
Session: Pfizer Oncology - Treatment considerations in biomarker-driven NSCLC: Diagnostics and sequencing
Resources:
Webcast
Taking the pulse of personalised healthcare today
Presenter: Emile Voest
Session: F. Hoffmann-La Roche - Putting personalised healthcare at the heart of clinical practice
Resources:
Webcast
Tracing our path with current tools
Presenter: Shumei Kato
Session: F. Hoffmann-La Roche - Putting personalised healthcare at the heart of clinical practice
Resources:
Webcast
If tissue is the issue, think blood
Presenter: Natalie Cook
Session: F. Hoffmann-La Roche - Putting personalised healthcare at the heart of clinical practice
Resources:
Webcast
Learning from real-world patients, in real-life conditions
Presenter: Kenneth Kehl
Session: F. Hoffmann-La Roche - Putting personalised healthcare at the heart of clinical practice
Resources:
Webcast
Looking at where personalised healthcare has become reality
Presenter: Emile Voest
Session: F. Hoffmann-La Roche - Putting personalised healthcare at the heart of clinical practice
Resources:
Webcast
Conclusion
Presenter: Emile Voest
Session: F. Hoffmann-La Roche - Putting personalised healthcare at the heart of clinical practice
Resources:
Webcast